FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040389973> ?p ?o ?g. }

• W2040389973 endingPage "5922" @default.
• W2040389973 startingPage "5912" @default.
• W2040389973 abstract "The processes associated with transition to castration-resistant prostate cancer (PC) growth are not well understood. Cellular senescence is a stable cell cycle arrest that occurs in response to sublethal stress. It is often overcome in malignant transformation to confer a survival advantage. CCAAT/Enhancer Binding Protein (C/EBP) β function is frequently deregulated in human malignancies and interestingly, androgen-sensitive PC cells express primarily the liver-enriched inhibitory protein isoform. We found that C/EBPβ expression is negatively regulated by androgen receptor (AR) activity and that treatment of androgen-sensitive cell lines with anti-androgens increases C/EBPβ mRNA and protein levels. Accordingly, we also find that C/EBPβ levels are significantly elevated in primary PC samples from castration-resistant compared with therapy-naive patients. Chromatin immunoprecipitation demonstrated enhanced binding of the AR to the proximal promoter of the CEBPB gene in the presence of dihydroxytestosterone. Upon androgen deprivation, induction of C/EBPβ is facilitated by active transcription as evident by increased histone 3 acetylation at the C/EBPβ promoter. Also, the androgen agonist R1881 suppresses the activity of a CEBPB promoter reporter. Loss of C/EBPβ expression prevents growth arrest following androgen deprivation or anti-androgen challenge. Accordingly, suppression of C/EBPβ under low androgen conditions results in reduced expression of senescence-associated secretory genes, significantly decreased number of cells displaying heterochromatin foci and increased numbers of Ki67-positive cells. Ectopic expression of C/EBPβ caused pronounced morphological changes, reduced PC cell growth and increased the number of senescent LNCaP cells. Lastly, we found that senescence contributes to PC cell survival under androgen deprivation, and C/EBPβ-deficient cells were significantly more susceptible to killing by cytotoxic chemotherapy following androgen deprivation. Our data demonstrate that upregulation of C/EBPβ is critical for complete maintenance of androgen deprivation-induced senescence and that targeting C/EBPβ expression may synergize with anti-androgen or chemotherapy in eradicating PC." @default.
• W2040389973 created "2016-06-24" @default.
• W2040389973 creator A5001771354 @default.
• W2040389973 creator A5002253253 @default.
• W2040389973 creator A5017033498 @default.
• W2040389973 creator A5017947172 @default.
• W2040389973 creator A5020690225 @default.
• W2040389973 creator A5081348983 @default.
• W2040389973 date "2015-03-16" @default.
• W2040389973 modified "2023-10-02" @default.
• W2040389973 title "CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells" @default.
• W2040389973 cites W1211637162 @default.
• W2040389973 cites W1502076440 @default.
• W2040389973 cites W1600357478 @default.
• W2040389973 cites W1975069346 @default.
• W2040389973 cites W1998691242 @default.
• W2040389973 cites W1999068651 @default.
• W2040389973 cites W2000072973 @default.
• W2040389973 cites W2000846615 @default.
• W2040389973 cites W2002686926 @default.
• W2040389973 cites W2004836615 @default.
• W2040389973 cites W2008254158 @default.
• W2040389973 cites W2010345740 @default.
• W2040389973 cites W2010594261 @default.
• W2040389973 cites W2016124553 @default.
• W2040389973 cites W2031465452 @default.
• W2040389973 cites W2038208558 @default.
• W2040389973 cites W2039744584 @default.
• W2040389973 cites W2041034966 @default.
• W2040389973 cites W2044341880 @default.
• W2040389973 cites W2045457909 @default.
• W2040389973 cites W2048634508 @default.
• W2040389973 cites W2051025382 @default.
• W2040389973 cites W2064649210 @default.
• W2040389973 cites W2069367373 @default.
• W2040389973 cites W2076978182 @default.
• W2040389973 cites W2080339543 @default.
• W2040389973 cites W2082668371 @default.
• W2040389973 cites W2087999409 @default.
• W2040389973 cites W2089269914 @default.
• W2040389973 cites W2092333751 @default.
• W2040389973 cites W2093397186 @default.
• W2040389973 cites W2097014721 @default.
• W2040389973 cites W2098622645 @default.
• W2040389973 cites W2106797957 @default.
• W2040389973 cites W2110720974 @default.
• W2040389973 cites W2115852450 @default.
• W2040389973 cites W2116842394 @default.
• W2040389973 cites W2123910382 @default.
• W2040389973 cites W2124265904 @default.
• W2040389973 cites W2124614845 @default.
• W2040389973 cites W2128154969 @default.
• W2040389973 cites W2131078803 @default.
• W2040389973 cites W2132362370 @default.
• W2040389973 cites W2135829603 @default.
• W2040389973 cites W2136294116 @default.
• W2040389973 cites W2140150237 @default.
• W2040389973 cites W2149898827 @default.
• W2040389973 cites W2154856535 @default.
• W2040389973 cites W2155894543 @default.
• W2040389973 cites W2158771952 @default.
• W2040389973 cites W2159674010 @default.
• W2040389973 cites W2160279897 @default.
• W2040389973 cites W2161206704 @default.
• W2040389973 cites W2161879447 @default.
• W2040389973 cites W2168229622 @default.
• W2040389973 cites W2168245648 @default.
• W2040389973 cites W2170032500 @default.
• W2040389973 cites W2620449613 @default.
• W2040389973 cites W4232547688 @default.
• W2040389973 cites W4296404860 @default.
• W2040389973 cites W90182880 @default.
• W2040389973 doi "https://doi.org/10.1038/onc.2015.41" @default.
• W2040389973 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4573387" @default.
• W2040389973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25772238" @default.
• W2040389973 hasPublicationYear "2015" @default.
• W2040389973 type Work @default.
• W2040389973 sameAs 2040389973 @default.
• W2040389973 citedByCount "32" @default.
• W2040389973 countsByYear W20403899732015 @default.
• W2040389973 countsByYear W20403899732016 @default.
• W2040389973 countsByYear W20403899732017 @default.
• W2040389973 countsByYear W20403899732018 @default.
• W2040389973 countsByYear W20403899732019 @default.
• W2040389973 countsByYear W20403899732020 @default.
• W2040389973 countsByYear W20403899732021 @default.
• W2040389973 countsByYear W20403899732022 @default.
• W2040389973 countsByYear W20403899732023 @default.
• W2040389973 crossrefType "journal-article" @default.
• W2040389973 hasAuthorship W2040389973A5001771354 @default.
• W2040389973 hasAuthorship W2040389973A5002253253 @default.
• W2040389973 hasAuthorship W2040389973A5017033498 @default.
• W2040389973 hasAuthorship W2040389973A5017947172 @default.
• W2040389973 hasAuthorship W2040389973A5020690225 @default.
• W2040389973 hasAuthorship W2040389973A5081348983 @default.
• W2040389973 hasBestOaLocation W20403899731 @default.
• W2040389973 hasConcept C101762097 @default.
• W2040389973 hasConcept C104317684 @default.

• next